“anti-TNF drugs”的搜索结果，显示 921-930 项，共有 6887 项

1. 血液科- 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... therapy are unknown. In addition, relatively ... The purpose of this study is to determine the preliminary anti-tumor activity and confirm the safety of VV1 ...

3. 肾病和高血压- 临床试验- 妙佑医疗国际

   Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this trial is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics (PK), pharmacodynamics (PD), and anti ... Drugs used in ...

5. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

6. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

7. 血液科- 临床试验- 妙佑医疗国际

   Other drugs used in the chemotherapy regimen, such as cyclophosphamide, cytarabine, dexamethasone, doxorubicin, daunorubicin, methotrexate, leucovorin ...

8. 神经科- 临床试验- 妙佑医疗国际

   Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual Chemotherapy Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous ...

9. 淋巴瘤- 诊断与治疗

   ... treatment · 申请预约. 临床试验. 探索Mayo Clinic 的 ... Mayo Clinic researcher leads Lancet commission reports on life during and after blood cancer treatment ...

10. 血液科- 临床试验- 妙佑医疗国际

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...